TCI Wealth Advisors’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-300
Closed -$5K 2170
2023
Q1
$5K Hold
300
﹤0.01% 1531
2022
Q4
$2.82K Hold
300
﹤0.01% 1886
2022
Q3
$1K Hold
300
﹤0.01% 2177
2022
Q2
$1K Hold
300
﹤0.01% 2216
2022
Q1
$1K Sell
300
-840
-74% -$3.01K ﹤0.01% 2159
2021
Q4
$5K Buy
1,140
+840
+280% +$4.71K ﹤0.01% 1731
2021
Q3
$2K Hold
300
﹤0.01% 2187
2021
Q2
$2K Sell
300
-100
-25% -$594 ﹤0.01% 2112
2021
Q1
$3K Hold
400
﹤0.01% 1603
2020
Q4
$2K Sell
400
-100
-20% -$606 ﹤0.01% 1288
2020
Q3
$3K Sell
500
-400
-44% -$2.75K ﹤0.01% 1023
2020
Q2
$6K Hold
900
﹤0.01% 705
2020
Q1
$4K Hold
900
﹤0.01% 801
2019
Q4
$7K Sell
900
-300
-25% -$2.19K ﹤0.01% 792
2019
Q3
$8K Buy
1,200
+100
+9% +$743 ﹤0.01% 707
2019
Q2
$9K Sell
1,100
-100
-8% -$855 ﹤0.01% 660
2019
Q1
$12K Sell
1,200
-300
-20% -$2.51K 0.01% 603
2018
Q4
$11K Buy
1,500
+300
+25% +$3.59K 0.01% 609
2018
Q3
$21K Buy
1,200
+400
+50% +$4.76K 0.01% 497
2018
Q2
$8K Buy
800
+500
+167% +$3.33K ﹤0.01% 691
2018
Q1
$1K Buy
+300
New +$1.66K ﹤0.01% 1238

Other funds holding VKTX

TCI Wealth Advisors's VKTX Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Viking Therapeutics (VKTX) in Q2 2023, closing a stake of 300 shares — an estimated $5K sold.

TCI Wealth Advisors first reported a position in VKTX in Q1 2018 and held it in 21 quarters. The position peaked at $21K in Q3 2018. 193 funds tracked by Wall St. Rank hold VKTX as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Viking Therapeutics position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 300 Viking Therapeutics shares in Q2 2023, an estimated $5K.
  • TCI Wealth Advisors first reported a position in Viking Therapeutics in Q1 2018 and held it in 21 quarters.
  • TCI Wealth Advisors's Viking Therapeutics position peaked at $21K in Q3 2018.
  • 193 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.